Low Risk of Serological Cross-Reactivity between the Dengue Virus and SARS-CoV-2-IgG Antibodies Using Advanced Detection Assays.
Intervirology
; 65(4): 224-229, 2022.
Article
in En
| MEDLINE
| ID: mdl-35134813
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dengue Virus
/
COVID-19
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Intervirology
Year:
2022
Document type:
Article
Affiliation country:
Qatar
Country of publication:
Suiza